REGADENOSON

REGADENOSON was reported 4773 times

REGADENOSON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRIEF PSYCHOTIC DISORDER WITHOUT MARKED STRESSORS 1 0.2500
1 CORONARY STEAL SYNDROME 3 0.2000
2 RADIOISOTOPE UPTAKE INCREASED 4 0.0909
3 CARDIAC PERFUSION DEFECT 4 0.0755
4 RADIATION OVERDOSE 4 0.0741
5 AMPHETAMINES 1 0.0625
6 FAILED EXAMINATIONS 1 0.0588
7 BRONCHITIS CHEMICAL 1 0.0500
8 ACTIVITIES OF DAILY LIVING ASSESSMENT 1 0.0500
9 JOINT VIBRATION 1 0.0476
10 ELECTROCARDIOGRAM RR INTERVAL PROLONGED 2 0.0444
11 HEMIPLEGIC MIGRAINE 14 0.0413
12 ADMINISTRATION SITE MASS 1 0.0357
13 CONJUNCTIVAL GRANULOMA 1 0.0345
14 HAIR METAL TEST ABNORMAL 1 0.0323
15 ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION 2 0.0303
16 INJECTION SITE EXTRAVASATION 361 0.0292
17 SINUS ARREST 41 0.0261
18 SCAN MYOCARDIAL PERFUSION ABNORMAL 4 0.0260
19 EXERCISE ELECTROCARDIOGRAM ABNORMAL 2 0.0241
20 CARDIAC IMAGING PROCEDURE ABNORMAL 1 0.0238
21 INTESTINAL ANGINA 1 0.0238
22 PITUITARY APOPLEXY 4 0.0227
23 ELECTROCARDIOGRAM QRS COMPLEX 1 0.0227
24 CORONARY VASCULAR GRAFT OCCLUSION 1 0.0227
25 CAROTID PULSE DECREASED 1 0.0222
26 DEVICE LEAD DAMAGE 1 0.0208
27 ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0204
28 THERAPEUTIC PRODUCT EFFECT PROLONGED 9 0.0199
29 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 39 0.0177
30 INTERCEPTED WRONG PATIENT SELECTED 1 0.0175
31 NODAL RHYTHM 25 0.0171
32 CARDIAC STRESS TEST 2 0.0157
33 ATRIOVENTRICULAR BLOCK SECOND DEGREE 44 0.0145
34 COMPLICATED MIGRAINE 1 0.0141
35 SEIZURE LIKE PHENOMENA 23 0.0135
36 ELECTROCARDIOGRAM CHANGE 12 0.0126
37 ARTERIAL CATHETERISATION 1 0.0122
38 EXTRAVASATION 48 0.0117
39 ATRIOVENTRICULAR BLOCK COMPLETE 74 0.0110
40 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 9 0.0110
41 GENITAL PARAESTHESIA 3 0.0103
42 AGONAL RHYTHM 1 0.0103
43 ATRIOVENTRICULAR BLOCK 77 0.0100
44 INFUSION SITE EXTRAVASATION 58 0.0093
45 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 30 0.0090
46 FASCIOTOMY 1 0.0089
47 PSYCHOGENIC SEIZURE 8 0.0086
48 CARDIAC PROCEDURE COMPLICATION 5 0.0082
49 ELECTROCARDIOGRAM P WAVE ABNORMAL 2 0.0082
50 ADMINISTRATION SITE EXTRAVASATION 8 0.0080
51 EXPOSURE TO RADIATION 1 0.0079
52 ENZYME LEVEL DECREASED 1 0.0076
53 ALKALOSIS HYPOCHLORAEMIC 1 0.0071
54 FALSE NEGATIVE INVESTIGATION RESULT 5 0.0071
55 DEVICE COMPONENT ISSUE 1 0.0068
56 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 1 0.0068
57 INTRA-ABDOMINAL PRESSURE INCREASED 1 0.0064
58 IMMEDIATE POST-INJECTION REACTION 7 0.0064
59 UNRESPONSIVE TO STIMULI 164 0.0063
60 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 2 0.0062
61 ADMINISTRATION SITE SWELLING 2 0.0062
62 VEIN RUPTURE 10 0.0060
63 PHLEBOLITH 1 0.0059
64 LABELLED DRUG-FOOD INTERACTION ISSUE 1 0.0059
65 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0057
66 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
67 SCAN ABNORMAL 2 0.0054
68 CELLULITIS GANGRENOUS 1 0.0051
69 PHYSICAL PRODUCT LABEL ISSUE 6 0.0050
70 GENITAL ABSCESS 2 0.0050
71 PULSE ABSENT 23 0.0048
72 ELECTROCARDIOGRAM PR SHORTENED 1 0.0048
73 CONTRAST MEDIA REACTION 11 0.0047
74 BUNDLE BRANCH BLOCK LEFT 19 0.0045
75 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 1 0.0044
76 GRIP STRENGTH 1 0.0044
77 CARDIAC SARCOIDOSIS 1 0.0043
78 ELECTROCARDIOGRAM ST-T CHANGE 3 0.0042
79 BIOPSY SKIN ABNORMAL 1 0.0041
80 BLOOD PRESSURE IMMEASURABLE 6 0.0039
81 CYANOSIS CENTRAL 1 0.0038
82 DEVICE CONNECTION ISSUE 8 0.0038
83 INAPPROPRIATE AFFECT 6 0.0038
84 CENTRAL PAIN SYNDROME 1 0.0038
85 CSF PRESSURE INCREASED 1 0.0038
86 ARTERIOSPASM CORONARY 15 0.0037
87 FACIAL WASTING 1 0.0037
88 BRADYCARDIA 196 0.0037
89 INCORRECT PRODUCT ADMINISTRATION DURATION 80 0.0037
90 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16 0.0037
91 CHEMICAL BURNS OF EYE 1 0.0036
92 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
93 MOANING 4 0.0035
94 PERCUTANEOUS CORONARY INTERVENTION 1 0.0035
95 CARDIAC ARREST 284 0.0034
96 GASTROINTESTINAL ARTERIOVENOUS MALFORMATION 1 0.0034
97 SINOATRIAL BLOCK 2 0.0034
98 BLOOD PRESSURE DECREASED 208 0.0031
99 KOUNIS SYNDROME 7 0.0031
100 BLOOD PRESSURE SYSTOLIC DECREASED 14 0.0031
101 SINUS ARRHYTHMIA 4 0.0031
102 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
103 GENITAL INFECTION 1 0.0030
104 INJECTION RELATED REACTION 5 0.0030
105 FEMALE ORGASMIC DISORDER 1 0.0030
106 BLOOD VISCOSITY DECREASED 1 0.0030
107 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
108 ALCOHOLIC LIVER DISEASE 1 0.0029
109 GAS GANGRENE 1 0.0029
110 DIAPHRAGMALGIA 1 0.0029
111 OVARIAN CANCER STAGE III 1 0.0029
112 PRESYNCOPE 70 0.0029
113 DILATATION VENTRICULAR 6 0.0029
114 HEART RATE DECREASED 100 0.0028
115 GLASSY EYES 2 0.0028
116 TONGUE PARALYSIS 2 0.0028
117 VENTRICULAR EXTRASYSTOLES 29 0.0028
118 VOMITING PROJECTILE 8 0.0028
119 AXILLARY VEIN THROMBOSIS 1 0.0027
120 CARDIAC ASSISTANCE DEVICE USER 1 0.0027
121 PUPILS UNEQUAL 3 0.0026
122 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
123 SICK SINUS SYNDROME 3 0.0026
124 CONVERSION DISORDER 5 0.0026
125 MYOCARDIAL OEDEMA 1 0.0025
126 ABDOMINAL SYMPTOM 2 0.0025
127 DEVICE COLOUR ISSUE 1 0.0025
128 TONGUE ERYTHEMA 2 0.0024
129 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
130 NODAL ARRHYTHMIA 2 0.0023
131 BRONCHOSPASM 32 0.0022
132 PERINEAL ABSCESS 1 0.0022
133 SEIZURE 256 0.0022
134 SINUS NODE DYSFUNCTION 4 0.0022
135 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0022
136 ISCHAEMIA 10 0.0022
137 LOCKED-IN SYNDROME 1 0.0022
138 ADRENAL NEOPLASM 1 0.0021
139 VENTRICULAR FIBRILLATION 23 0.0021
140 BRAIN STEM STROKE 1 0.0020
141 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
142 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
143 SINUS BRADYCARDIA 19 0.0020
144 CAPILLARY FRAGILITY 1 0.0020
145 PATELLOFEMORAL PAIN SYNDROME 1 0.0019
146 POSTICTAL STATE 2 0.0019
147 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
148 DEVICE USE CONFUSION 1 0.0019
149 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
150 INFUSION SITE PAIN 24 0.0019
151 FRACTURE PAIN 1 0.0019
152 INCORRECT DRUG ADMINISTRATION DURATION 52 0.0018
153 EPIGLOTTITIS 1 0.0018
154 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
155 DRUG EFFECT PROLONGED 1 0.0018
156 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
157 BLOOD MAGNESIUM ABNORMAL 1 0.0018
158 SENSATION OF HEAVINESS 7 0.0018
159 INTENTION TREMOR 1 0.0018
160 EYE MOVEMENT DISORDER 12 0.0018
161 COLLAGEN DISORDER 1 0.0017
162 MEDIASTINITIS 1 0.0017
163 STRIDOR 5 0.0017
164 GROIN ABSCESS 2 0.0017
165 MEAN PLATELET VOLUME INCREASED 1 0.0017
166 RETCHING 35 0.0016
167 CONTRAST MEDIA ALLERGY 3 0.0016
168 CONDUCTION DISORDER 3 0.0016
169 TUNNEL VISION 3 0.0016
170 DRUG LEVEL CHANGED 1 0.0016
171 HYPOTENSION 315 0.0016
172 INFUSION SITE IRRITATION 2 0.0016
173 ANAL INCONTINENCE 14 0.0016
174 ENTEROCOCCUS TEST POSITIVE 1 0.0015
175 SLOW RESPONSE TO STIMULI 2 0.0015
176 KLEBSIELLA TEST POSITIVE 1 0.0015
177 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
178 GINGIVAL DISCOMFORT 1 0.0015
179 VENTRICULAR TACHYCARDIA 25 0.0015
180 INFUSION SITE URTICARIA 1 0.0015
181 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
182 LOSS OF CONSCIOUSNESS 190 0.0015
183 EYE ROLLING 1 0.0014
184 BORDERLINE PERSONALITY DISORDER 1 0.0014
185 DELAYED GRAFT FUNCTION 1 0.0014
186 MYOCARDIAL ISCHAEMIA 16 0.0014
187 INJECTION SITE HYPOAESTHESIA 2 0.0014
188 ACUTE MYOCARDIAL INFARCTION 41 0.0014
189 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
190 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
191 EXCESSIVE EYE BLINKING 2 0.0014
192 APRAXIA 2 0.0013
193 AMPHETAMINES POSITIVE 1 0.0013
194 SYRINGE ISSUE 23 0.0013
195 RESPIRATORY ARREST 36 0.0013
196 HEART RATE INCREASED 129 0.0013
197 CRITICAL ILLNESS 1 0.0013
198 EYELID FUNCTION DISORDER 1 0.0013
199 NON-CARDIAC CHEST PAIN 4 0.0013
200 CHEST PAIN 233 0.0013
201 ACUTE PULMONARY OEDEMA 7 0.0012
202 IIIRD NERVE PARALYSIS 1 0.0012
203 PRODUCT PACKAGING CONFUSION 3 0.0012
204 SLOW SPEECH 3 0.0012
205 SKULL FRACTURE 2 0.0012
206 CHEMICAL INJURY 1 0.0012
207 BRADYARRHYTHMIA 2 0.0012
208 RESUSCITATION 2 0.0012
209 CARDIAC STRESS TEST ABNORMAL 1 0.0012
210 STRESS CARDIOMYOPATHY 7 0.0012
211 HYPERPARATHYROIDISM SECONDARY 3 0.0012
212 PHLEBITIS 6 0.0012
213 LIP PRURITUS 1 0.0012
214 ALLERGIC SINUSITIS 1 0.0012
215 INJECTION SITE OEDEMA 2 0.0012
216 GINGIVAL ERYTHEMA 1 0.0012
217 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
218 SYNCOPE 115 0.0011
219 ARTERIAL STENOSIS 1 0.0011
220 CARDIAC OUTPUT DECREASED 1 0.0011
221 TREMOR 188 0.0011
222 APHASIA 34 0.0011
223 INFUSION SITE SWELLING 7 0.0011
224 PALLOR 30 0.0011
225 INCOHERENT 7 0.0011
226 NEPHROGENIC ANAEMIA 5 0.0011
227 COLD SWEAT 19 0.0011
228 PHARYNGEAL HYPOAESTHESIA 1 0.0011
229 HEART RATE ABNORMAL 6 0.0011
230 THERAPEUTIC RESPONSE DELAYED 3 0.0011
231 ENDOTRACHEAL INTUBATION 3 0.0011
232 BUNDLE BRANCH BLOCK 1 0.0011
233 CHEST DISCOMFORT 108 0.0011
234 FACIAL ASYMMETRY 1 0.0010
235 PROCEDURAL COMPLICATION 8 0.0010
236 FAECAL INCONTINENCE 5 0.0010
237 CARDIAC DISCOMFORT 2 0.0010
238 CORONARY ARTERY THROMBOSIS 2 0.0010
239 FOAMING AT MOUTH 2 0.0010
240 CONVULSION 56 0.0010
241 MENTAL STATUS CHANGES 27 0.0010
242 VENOUS THROMBOSIS LIMB 2 0.0010
243 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
244 AXILLARY MASS 1 0.0010
245 RESPIRATORY RATE DECREASED 3 0.0010
246 PARTIAL SEIZURES 5 0.0010
247 HYPOPERFUSION 1 0.0010
248 HEMIPARESIS 16 0.0009
249 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
250 NEUROMYOPATHY 1 0.0009
251 FACIAL PARALYSIS 8 0.0009
252 JOINT CONTRACTURE 1 0.0009
253 BRUXISM 5 0.0009
254 FACIAL PALSY 2 0.0009
255 THROAT TIGHTNESS 25 0.0009
256 POSTURE ABNORMAL 3 0.0009
257 COMPLEX PARTIAL SEIZURES 1 0.0009
258 CARDIAC HYPERTROPHY 1 0.0009
259 FACIAL SPASM 1 0.0009
260 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
261 ATRIAL FLUTTER 7 0.0009
262 BLOOD FIBRINOGEN DECREASED 1 0.0009
263 MICTURITION URGENCY 10 0.0009
264 PELVIC ABSCESS 1 0.0009
265 VIITH NERVE PARALYSIS 3 0.0009
266 ADMINISTRATION SITE PAIN 1 0.0009
267 ACUTE PRERENAL FAILURE 1 0.0009
268 HYPERVENTILATION 5 0.0009
269 CARDIO-RESPIRATORY ARREST 36 0.0009
270 HYPORESPONSIVE TO STIMULI 1 0.0009
271 DRUG ADMINISTRATION ERROR 26 0.0008
272 LABILE BLOOD PRESSURE 1 0.0008
273 PULSE ABNORMAL 2 0.0008
274 CHRONIC RESPIRATORY FAILURE 1 0.0008
275 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
276 CEREBRAL ARTERY EMBOLISM 1 0.0008
277 AORTIC VALVE REPLACEMENT 1 0.0008
278 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
279 CORONARY ARTERY STENOSIS 4 0.0008
280 BLEPHAROSPASM 5 0.0008
281 MALLORY-WEISS SYNDROME 1 0.0008
282 COMMUNICATION DISORDER 3 0.0008
283 PETIT MAL EPILEPSY 4 0.0008
284 PAIN IN JAW 22 0.0008
285 APNOEA 6 0.0008
286 ANGINA UNSTABLE 5 0.0008
287 EPIGASTRIC DISCOMFORT 3 0.0008
288 APPLICATION SITE PARAESTHESIA 1 0.0008
289 LIP INJURY 1 0.0008
290 VOMITING 358 0.0008
291 INCORRECT PRODUCT STORAGE 10 0.0008
292 INJECTION SITE DISCOMFORT 8 0.0008
293 INCONTINENCE 8 0.0008
294 ACROCHORDON 1 0.0008
295 YAWNING 2 0.0007
296 WHEEZING 44 0.0007
297 HEAD TITUBATION 1 0.0007
298 DROOLING 5 0.0007
299 DYSPNOEA 409 0.0007
300 EXTRASYSTOLES 5 0.0007
301 CULTURE URINE POSITIVE 1 0.0007
302 CONNECTIVE TISSUE DISORDER 1 0.0007
303 SINUS TACHYCARDIA 10 0.0007
304 PANIC REACTION 5 0.0007
305 MUTISM 1 0.0007
306 GENERALISED ANXIETY DISORDER 1 0.0007
307 HYPERHIDROSIS 87 0.0007
308 HYPERTHERMIA MALIGNANT 1 0.0007
309 IMPETIGO 1 0.0007
310 FLUSHING 67 0.0007
311 TROPONIN INCREASED 5 0.0007
312 CORONARY ARTERY OCCLUSION 9 0.0007
313 FEELING COLD 18 0.0006
314 COAGULATION TIME PROLONGED 1 0.0006
315 ORAL MUCOSAL ERYTHEMA 1 0.0006
316 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
317 NAUSEA 511 0.0006
318 BRONCHIAL DISORDER 1 0.0006
319 MUSCLE TIGHTNESS 10 0.0006
320 RESPIRATORY DISTRESS 17 0.0006
321 COSTOCHONDRITIS 1 0.0006
322 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
323 ACUTE CORONARY SYNDROME 5 0.0006
324 ANEURYSM 3 0.0006
325 HEMIPLEGIA 5 0.0006
326 SENSATION OF FOREIGN BODY 5 0.0006
327 COLITIS ISCHAEMIC 4 0.0006
328 CORONARY ARTERIAL STENT INSERTION 3 0.0006
329 PRODUCT LABEL ISSUE 4 0.0006
330 GAZE PALSY 1 0.0006
331 ATRIAL FIBRILLATION 57 0.0006
332 REGURGITATION 2 0.0006
333 RESPIRATION ABNORMAL 4 0.0006
334 ANAPHYLACTIC REACTION 32 0.0006
335 HYPOPNOEA 2 0.0006
336 URINARY INCONTINENCE 17 0.0006
337 LETHARGY 33 0.0006
338 CATATONIA 3 0.0006
339 RESPIRATORY DEPRESSION 7 0.0006
340 FANCONI SYNDROME ACQUIRED 1 0.0006
341 TYPE I HYPERSENSITIVITY 2 0.0006
342 EMBOLIC STROKE 2 0.0006
343 MITRAL VALVE DISEASE 1 0.0006
344 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
345 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
346 BLOOD PRESSURE INCREASED 86 0.0006
347 APPARENT DEATH 2 0.0006
348 DIZZINESS 276 0.0006
349 ESSENTIAL HYPERTENSION 1 0.0005
350 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
351 HYPERTENSIVE HEART DISEASE 1 0.0005
352 NARCOLEPSY 1 0.0005
353 CORONARY ARTERY DISEASE 16 0.0005
354 LIP DISORDER 1 0.0005
355 HYPERCOAGULATION 1 0.0005
356 HEADACHE 328 0.0005
357 SKIN WARM 3 0.0005
358 CARDIOPULMONARY FAILURE 2 0.0005
359 DIPLEGIA 1 0.0005
360 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
361 BLOOD PRESSURE FLUCTUATION 12 0.0005
362 PAIN IN EXTREMITY 147 0.0005
363 LIPIDS INCREASED 1 0.0005
364 BREAST DISORDER 1 0.0005
365 AKINESIA 1 0.0005
366 MUSCLE TWITCHING 11 0.0005
367 MUSCULOSKELETAL PAIN 25 0.0005
368 SPEECH DISORDER 25 0.0005
369 NEUROGENIC BLADDER 1 0.0005
370 FEELING JITTERY 9 0.0005
371 PHARYNGEAL ERYTHEMA 1 0.0005
372 POOR PERIPHERAL CIRCULATION 2 0.0005
373 ABNORMAL SENSATION IN EYE 2 0.0005
374 HYPERPHOSPHATAEMIA 1 0.0005
375 TACHYCARDIA 41 0.0005
376 CHOKING 9 0.0005
377 IMMOBILE 2 0.0005
378 DYSPHEMIA 2 0.0005
379 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
380 DIABETIC NEPHROPATHY 1 0.0005
381 ABDOMINAL DISCOMFORT 76 0.0005
382 BLOOD PRESSURE ABNORMAL 9 0.0005
383 LIMB DISCOMFORT 14 0.0005
384 PHYSICAL DISABILITY 2 0.0005
385 DYSARTHRIA 17 0.0005
386 EJECTION FRACTION DECREASED 7 0.0004
387 HYPERTENSIVE CRISIS 5 0.0004
388 SWOLLEN TONGUE 14 0.0004
389 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
390 FEAR OF DEATH 1 0.0004
391 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
392 IMPAIRED DRIVING ABILITY 5 0.0004
393 CEREBROVASCULAR ACCIDENT 74 0.0004
394 ORAL PRURITUS 1 0.0004
395 EYELID DISORDER 1 0.0004
396 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
397 INTERCEPTED MEDICATION ERROR 2 0.0004
398 NEPHROPATHY 4 0.0004
399 DEFAECATION URGENCY 3 0.0004
400 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
401 PRODUCT PACKAGING ISSUE 4 0.0004
402 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
403 PARALYSIS 6 0.0004
404 CARDIOGENIC SHOCK 6 0.0004
405 LACUNAR INFARCTION 1 0.0004
406 NO THERAPEUTIC RESPONSE 5 0.0004
407 MEDICAL DEVICE COMPLICATION 3 0.0004
408 DISORIENTATION 16 0.0004
409 DEVICE INFUSION ISSUE 1 0.0004
410 INJECTION SITE INFLAMMATION 2 0.0004
411 CATHETER SITE HAEMORRHAGE 1 0.0004
412 VEIN DISORDER 2 0.0004
413 DEVICE BREAKAGE 16 0.0004
414 APPENDICITIS PERFORATED 1 0.0004
415 INJECTION SITE IRRITATION 5 0.0004
416 BOWEL MOVEMENT IRREGULARITY 3 0.0004
417 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
418 MYOCARDIAL INFARCTION 68 0.0004
419 MEAN CELL VOLUME INCREASED 1 0.0004
420 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
421 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
422 BURNING SENSATION 27 0.0004
423 ANGINA PECTORIS 11 0.0004
424 TENDERNESS 4 0.0004
425 END STAGE RENAL DISEASE 7 0.0004
426 HYPERTENSION 81 0.0004
427 CYANOSIS 6 0.0004
428 ARRHYTHMIA 18 0.0004
429 DISCOMFORT 23 0.0004
430 BLOOD POTASSIUM ABNORMAL 1 0.0004
431 BREAST SWELLING 1 0.0004
432 MUSCLE SPASMS 68 0.0004
433 GAMBLING DISORDER 1 0.0004
434 CHEILITIS 2 0.0004
435 DEVICE LEAKAGE 16 0.0004
436 MIGRAINE WITH AURA 1 0.0004
437 CHOKING SENSATION 2 0.0004
438 HYPOAESTHESIA 54 0.0004
439 MACULE 1 0.0004
440 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
441 PRODUCT LEAKAGE 2 0.0004
442 OXYGEN SATURATION DECREASED 20 0.0004
443 GENERALISED ERYTHEMA 2 0.0004
444 EYE SWELLING 13 0.0003
445 PHARYNGEAL DISORDER 1 0.0003
446 HYPOKINESIA 5 0.0003
447 LOCAL SWELLING 6 0.0003
448 BILIARY COLIC 1 0.0003
449 DYSSTASIA 10 0.0003
450 NECK PAIN 19 0.0003
451 BACK PAIN 78 0.0003
452 MYOCLONUS 4 0.0003
453 BRAIN HERNIATION 1 0.0003
454 INFUSION SITE REACTION 1 0.0003
455 CEREBROVASCULAR DISORDER 1 0.0003
456 HYPOAESTHESIA ORAL 5 0.0003
457 CENTRAL VENOUS CATHETERISATION 1 0.0003
458 PELVIC PAIN 6 0.0003
459 CRYING 12 0.0003
460 TENSION 2 0.0003
461 DYSAESTHESIA 1 0.0003
462 BLOOD GLUCOSE ABNORMAL 6 0.0003
463 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
464 FEELING ABNORMAL 77 0.0003
465 INVESTIGATION 1 0.0003
466 ARTERIOSCLEROSIS 3 0.0003
467 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
468 SCREAMING 2 0.0003
469 EXPOSURE TO TOXIC AGENT 1 0.0003
470 POST PROCEDURAL COMPLICATION 6 0.0003
471 SNEEZING 7 0.0003
472 ACUTE RESPIRATORY FAILURE 6 0.0003
473 MYDRIASIS 4 0.0003
474 MOVEMENT DISORDER 10 0.0003
475 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
476 ATELECTASIS 3 0.0003
477 FEELING HOT 19 0.0003
478 HEART RATE IRREGULAR 7 0.0003
479 INJECTION SITE PAIN 95 0.0003
480 RENAL TUBULAR NECROSIS 3 0.0003
481 MIGRAINE 29 0.0003
482 NEAR DEATH EXPERIENCE 1 0.0003
483 PANIC ATTACK 11 0.0003
484 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
485 ABDOMINAL PAIN 70 0.0003
486 LIP SWELLING 10 0.0003
487 SALIVARY HYPERSECRETION 3 0.0003
488 URTICARIA 50 0.0003
489 QUALITY OF LIFE DECREASED 4 0.0003
490 PRODUCT ADMINISTRATION ERROR 6 0.0003
491 WRONG PRODUCT ADMINISTERED 2 0.0003
492 EYELID PTOSIS 3 0.0003
493 PERIPHERAL COLDNESS 4 0.0003
494 MUSCULOSKELETAL DISCOMFORT 5 0.0003
495 LEFT VENTRICULAR FAILURE 1 0.0003
496 GRANULOMA 1 0.0003
497 UNDERDOSE 21 0.0003
498 CAROTID ARTERY STENOSIS 1 0.0003
499 PARAESTHESIA 45 0.0003
500 HANGOVER 1 0.0003
501 HYPOXIA 10 0.0003
502 NECROTISING FASCIITIS 1 0.0003
503 SKIN DISCOLOURATION 13 0.0003
504 FACIAL PARESIS 1 0.0003
505 HEAD DISCOMFORT 5 0.0003
506 PALPITATIONS 33 0.0003
507 CHILLS 33 0.0003
508 NO ADVERSE EVENT 51 0.0003
509 FIBRIN D DIMER INCREASED 1 0.0003
510 APPENDICECTOMY 1 0.0003
511 MYALGIA 47 0.0003
512 TONGUE DISORDER 2 0.0003
513 BLINDNESS TRANSIENT 2 0.0003
514 GAIT INABILITY 9 0.0003
515 FEELING DRUNK 2 0.0003
516 OCULAR DISCOMFORT 3 0.0003
517 ABDOMINAL PAIN UPPER 55 0.0003
518 HYPERSENSITIVITY 49 0.0003
519 LOSS OF CONTROL OF LEGS 1 0.0003
520 DEVICE FAILURE 4 0.0003
521 MUSCULOSKELETAL STIFFNESS 23 0.0003
522 PANIC DISORDER 1 0.0003
523 TORSADE DE POINTES 2 0.0003
524 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
525 OESOPHAGEAL CANDIDIASIS 1 0.0003
526 MUSCLE RIGIDITY 3 0.0003
527 AZOTAEMIA 1 0.0003
528 SENSORY DISTURBANCE 4 0.0002
529 ANGIOEDEMA 11 0.0002
530 ORGAN FAILURE 1 0.0002
531 FEEDING DISORDER 5 0.0002
532 SWELLING FACE 16 0.0002
533 DIARRHOEA 156 0.0002
534 AORTIC DISSECTION 1 0.0002
535 INJECTION SITE DISCOLOURATION 3 0.0002
536 MALAISE 105 0.0002
537 INFUSION SITE ERYTHEMA 2 0.0002
538 LIP OEDEMA 1 0.0002
539 MUSCLE FATIGUE 1 0.0002
540 AORTIC VALVE INCOMPETENCE 1 0.0002
541 CARDIAC FAILURE CHRONIC 1 0.0002
542 INTERVERTEBRAL DISC DISORDER 1 0.0002
543 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
544 CARDIAC MURMUR 2 0.0002
545 MONOPLEGIA 1 0.0002
546 NERVOUSNESS 12 0.0002
547 GROIN PAIN 2 0.0002
548 HAEMORRHAGIC ANAEMIA 1 0.0002
549 GRIP STRENGTH DECREASED 2 0.0002
550 RESPIRATORY RATE INCREASED 2 0.0002
551 EYE HAEMORRHAGE 3 0.0002
552 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
553 FACIAL PAIN 2 0.0002
554 IMPLANT SITE PAIN 1 0.0002
555 PAPILLOEDEMA 1 0.0002
556 DYSKINESIA 9 0.0002
557 OROPHARYNGEAL DISCOMFORT 2 0.0002
558 TACHYPNOEA 3 0.0002
559 GRAND MAL CONVULSION 2 0.0002
560 PERFORMANCE STATUS DECREASED 1 0.0002
561 PRODUCT QUALITY ISSUE 29 0.0002
562 CHRONIC KIDNEY DISEASE 16 0.0002
563 INJECTION SITE SWELLING 16 0.0002
564 HYPOVOLAEMIC SHOCK 1 0.0002
565 BLOOD GLUCOSE DECREASED 10 0.0002
566 PARAESTHESIA ORAL 3 0.0002
567 HUMERUS FRACTURE 1 0.0002
568 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
569 FINGER DEFORMITY 1 0.0002
570 DIZZINESS POSTURAL 2 0.0002
571 ADVERSE EVENT 19 0.0002
572 HYPERVOLAEMIA 1 0.0002
573 FOOT OPERATION 1 0.0002
574 DIABETIC NEUROPATHY 1 0.0002
575 PULMONARY OEDEMA 9 0.0002
576 THROAT IRRITATION 9 0.0002
577 DYSPHAGIA 19 0.0002
578 ECONOMIC PROBLEM 3 0.0002
579 DYSLIPIDAEMIA 1 0.0002
580 DRY THROAT 2 0.0002
581 VISION BLURRED 27 0.0002
582 SUBARACHNOID HAEMORRHAGE 2 0.0002
583 MOTOR DYSFUNCTION 2 0.0002
584 EUPHORIC MOOD 2 0.0002
585 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
586 PHARYNGEAL OEDEMA 3 0.0002
587 PERIPHERAL VASCULAR DISORDER 1 0.0002
588 MUSCULAR WEAKNESS 22 0.0002
589 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
590 RESTLESSNESS 7 0.0002
591 PRODUCT ODOUR ABNORMAL 2 0.0002
592 BLOOD LACTIC ACID INCREASED 1 0.0002
593 ANORECTAL DISCOMFORT 1 0.0002
594 DECREASED ACTIVITY 2 0.0002
595 BEHAVIOUR DISORDER 1 0.0002
596 JAW DISORDER 1 0.0002
597 NONSPECIFIC REACTION 1 0.0002
598 GASTROINTESTINAL PAIN 2 0.0002
599 INTESTINAL ISCHAEMIA 1 0.0002
600 DEAFNESS UNILATERAL 1 0.0002
601 HYPERKERATOSIS 1 0.0002
602 GASTRIC ULCER HAEMORRHAGE 1 0.0002
603 INJECTION SITE INJURY 1 0.0002
604 ANGIOPATHY 1 0.0002
605 MITRAL VALVE INCOMPETENCE 2 0.0002
606 CHOLECYSTITIS ACUTE 1 0.0002
607 ASTHENIA 66 0.0002
608 NEUROLOGICAL SYMPTOM 1 0.0002
609 CORONARY ARTERY BYPASS 1 0.0002
610 EXERCISE TOLERANCE DECREASED 1 0.0002
611 MOUTH SWELLING 1 0.0002
612 DEVICE DEFECTIVE 3 0.0002
613 ORTHOSTATIC HYPOTENSION 3 0.0002
614 METABOLIC DISORDER 1 0.0002
615 EYELID OEDEMA 2 0.0002
616 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
617 OCULAR HYPERAEMIA 8 0.0002
618 ATAXIA 2 0.0002
619 CARDIAC PACEMAKER INSERTION 1 0.0002
620 RESPIRATORY DISORDER 5 0.0002
621 GANGRENE 1 0.0002
622 HEPATITIS B 1 0.0002
623 TOOTHACHE 3 0.0002
624 ERYTHEMA 34 0.0002
625 LARYNGEAL OEDEMA 1 0.0002
626 EMOTIONAL DISORDER 5 0.0002
627 CHOLANGITIS 1 0.0002
628 SWELLING 15 0.0002
629 SECRETION DISCHARGE 2 0.0002
630 DERMATITIS ALLERGIC 2 0.0002
631 MULTIPLE INJURIES 1 0.0002
632 ANXIETY 45 0.0002
633 ANAPHYLACTIC SHOCK 4 0.0002
634 ERUCTATION 3 0.0002
635 INJECTION SITE INDURATION 2 0.0002
636 DIPLOPIA 4 0.0002
637 NODULE 2 0.0002
638 BRADYPHRENIA 1 0.0002
639 ADVERSE REACTION 2 0.0002
640 CARDIAC FAILURE CONGESTIVE 12 0.0001
641 RASH PRURITIC 8 0.0001
642 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
643 INFARCTION 1 0.0001
644 JOINT EFFUSION 1 0.0001
645 DEVICE ISSUE 13 0.0001
646 COORDINATION ABNORMAL 2 0.0001
647 RASH MACULAR 5 0.0001
648 DEVICE OCCLUSION 2 0.0001
649 HAND FRACTURE 1 0.0001
650 EATING DISORDER 3 0.0001
651 CEREBRAL HAEMORRHAGE 5 0.0001
652 CARDIAC DISORDER 13 0.0001
653 CELLULITIS 7 0.0001
654 PRURITUS GENERALISED 3 0.0001
655 FLUID OVERLOAD 2 0.0001
656 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
657 CONFUSIONAL STATE 22 0.0001
658 CARDIOMYOPATHY 2 0.0001
659 HAEMORRHAGE INTRACRANIAL 2 0.0001
660 HYDRONEPHROSIS 1 0.0001
661 GENERAL SYMPTOM 1 0.0001
662 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
663 PLEURAL EFFUSION 8 0.0001
664 VERTIGO 8 0.0001
665 RASH 57 0.0001
666 DEVICE RELATED INFECTION 2 0.0001
667 MUSCULOSKELETAL CHEST PAIN 2 0.0001
668 ANKLE FRACTURE 2 0.0001
669 VISUAL IMPAIRMENT 16 0.0001
670 NERVOUS SYSTEM DISORDER 4 0.0001
671 HAEMORRHAGIC STROKE 1 0.0001
672 RENAL FAILURE 17 0.0001
673 DRUG SCREEN POSITIVE 1 0.0001
674 HEAD INJURY 4 0.0001
675 NASAL DISCOMFORT 1 0.0001
676 BLOOD ALBUMIN DECREASED 1 0.0001
677 GINGIVAL PAIN 1 0.0001
678 ABSCESS 2 0.0001
679 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
680 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
681 MYASTHENIA GRAVIS 1 0.0001
682 FRUSTRATION TOLERANCE DECREASED 1 0.0001
683 MUSCLE DISORDER 1 0.0001
684 FIBROMYALGIA 3 0.0001
685 AMNESIA 8 0.0001
686 AGITATION 9 0.0001
687 HYPERAESTHESIA 1 0.0001
688 PRODUCT SUBSTITUTION ISSUE 7 0.0001
689 ABASIA 3 0.0001
690 PHOTOSENSITIVITY REACTION 2 0.0001
691 MENSTRUAL DISORDER 1 0.0001
692 URINARY RETENTION 4 0.0001
693 BONE PAIN 7 0.0001
694 EYE PRURITUS 4 0.0001
695 HAEMATEMESIS 3 0.0001
696 CARDIOVASCULAR DISORDER 3 0.0001
697 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
698 CARDIAC OPERATION 1 0.0001
699 MUSCLE STRAIN 1 0.0001
700 GAIT DISTURBANCE 22 0.0001
701 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
702 ISCHAEMIC STROKE 2 0.0001
703 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
704 GASTROINTESTINAL DISORDER 10 0.0001
705 HAEMOLYTIC ANAEMIA 1 0.0001
706 MOBILITY DECREASED 8 0.0001
707 ACUTE KIDNEY INJURY 17 0.0001
708 LEUKOCYTOSIS 2 0.0001
709 RESTLESS LEGS SYNDROME 2 0.0001
710 TINNITUS 5 0.0001
711 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
712 NERVE COMPRESSION 1 0.0001
713 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
714 PERSONALITY CHANGE 1 0.0001
715 PAIN 66 0.0001
716 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
717 FLANK PAIN 1 0.0001
718 EYE PAIN 6 0.0001
719 PHOTOPHOBIA 2 0.0001
720 FRACTURE 2 0.0001
721 BLOOD URINE PRESENT 2 0.0001
722 MUSCULOSKELETAL DISORDER 2 0.0001
723 HYPERSOMNIA 3 0.0001
724 HYPERCHOLESTEROLAEMIA 1 0.0001
725 EAR PAIN 2 0.0001
726 PARKINSONISM 1 0.0001
727 PHARYNGEAL SWELLING 1 0.0001
728 HEPATOMEGALY 1 0.0001
729 SINUS DISORDER 2 0.0001
730 HAEMATOCRIT DECREASED 2 0.0001
731 BLOOD POTASSIUM DECREASED 3 0.0001
732 BRAIN INJURY 1 0.0001
733 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
734 TASTE DISORDER 2 0.0001
735 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
736 EAR DISCOMFORT 1 0.0001
737 PERIPHERAL SWELLING 15 0.0001
738 ASTHMA 11 0.0001
739 INJECTION SITE ERYTHEMA 12 0.0001
740 INCORRECT DOSE ADMINISTERED 22 0.0001
741 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
742 FULL BLOOD COUNT ABNORMAL 1 0.0001
743 SOMNOLENCE 19 0.0001
744 DYSGEUSIA 7 0.0001
745 BREAST PAIN 1 0.0001
746 OESOPHAGITIS 1 0.0001
747 ASPIRATION 1 0.0001
748 EYE DISORDER 3 0.0001
749 INFUSION RELATED REACTION 6 0.0001
750 FOOT DEFORMITY 1 0.0001
751 MEDICATION ERROR 5 0.0001
752 BLISTER 5 0.0001
753 BLOOD CALCIUM DECREASED 1 0.0001
754 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
755 FATIGUE 69 0.0001
756 NEPHROLITHIASIS 4 0.0001
757 CARDIAC FAILURE 7 0.0001
758 HYPOKALAEMIA 4 0.0001
759 METASTASES TO LUNG 1 0.0001
760 PERICARDIAL EFFUSION 2 0.0001
761 MADAROSIS 1 0.0001
762 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
763 BACTERAEMIA 1 0.0001
764 ACCIDENT 1 0.0001
765 HYPERLIPIDAEMIA 1 0.0001
766 HYPOGLYCAEMIA 4 0.0001
767 RESPIRATORY FAILURE 6 0.0001
768 ENCEPHALOPATHY 2 0.0001
769 CARDIOMEGALY 1 0.0001
770 INJECTION SITE MASS 3 0.0001
771 HYPERCALCAEMIA 1 0.0001
772 GENERALISED OEDEMA 1 0.0001
773 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
774 HAIR COLOUR CHANGES 1 0.0001
775 INTRAOCULAR PRESSURE INCREASED 1 0.0001
776 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
777 ARTHRALGIA 32 0.0001
778 JOINT STIFFNESS 2 0.0001
779 BEDRIDDEN 1 0.0001
780 ANKYLOSING SPONDYLITIS 1 0.0001
781 FEAR 2 0.0001
782 FREQUENT BOWEL MOVEMENTS 2 0.0001
783 IMPAIRED GASTRIC EMPTYING 1 0.0001
784 OFF LABEL USE 64 0.0001
785 OSTEOPOROSIS 3 0.0001
786 PRURITUS 28 0.0001
787 CONTUSION 7 0.0001
788 ORAL DISCOMFORT 1 0.0001
789 HYPOMAGNESAEMIA 1 0.0001
790 HAEMOPTYSIS 2 0.0001
791 APHONIA 1 0.0001
792 DEMENTIA 2 0.0001
793 DEVICE MALFUNCTION 5 0.0001
794 BLINDNESS UNILATERAL 1 0.0001
795 RENAL FAILURE ACUTE 3 0.0001
796 DIALYSIS 1 0.0001
797 RED BLOOD CELL COUNT DECREASED 2 0.0001
798 ACCIDENTAL UNDERDOSE 1 0.0001
799 ANOSMIA 1 0.0001
800 DYSPHONIA 4 0.0001
801 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
802 COUGH 19 0.0001
803 RENAL INJURY 2 0.0001
804 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
805 HOT FLUSH 5 0.0001
806 LACRIMATION INCREASED 2 0.0001
807 FALL 22 0.0001
808 UNEVALUABLE EVENT 5 0.0001
809 OSTEOPENIA 1 0.0001
810 RENAL DISORDER 3 0.0001
811 COGNITIVE DISORDER 3 0.0001
812 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
813 DRUG INTERACTION 10 0.0001
814 COMA 3 0.0001
815 PRODUCTIVE COUGH 3 0.0001
816 HYPOTHYROIDISM 2 0.0001
817 DEEP VEIN THROMBOSIS 4 0.0001
818 LUNG DISORDER 3 0.0001
819 METASTASES TO BONE 1 0.0001
820 MULTIPLE FRACTURES 1 0.0001
821 DEATH 52 0.0001
822 EXPIRED PRODUCT ADMINISTERED 2 0.0001
823 COAGULOPATHY 1 0.0001
824 CIRCULATORY COLLAPSE 1 0.0001
825 METRORRHAGIA 1 0.0001
826 INJECTION SITE REACTION 4 0.0001
827 ABDOMINAL DISTENSION 6 0.0001
828 OEDEMA PERIPHERAL 7 0.0001
829 DEVICE USE ISSUE 1 0.0001
830 METASTASES TO LIVER 1 0.0001
831 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
832 LYMPHOCYTE COUNT DECREASED 1 0.0001
833 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
834 DRUG ERUPTION 1 0.0001
835 ADVERSE DRUG REACTION 5 0.0001
836 HYPERGLYCAEMIA 2 0.0001
837 BONE DISORDER 1 0.0001
838 HYPONATRAEMIA 3 0.0001
839 BLOOD GLUCOSE INCREASED 10 0.0001
840 BLOOD SODIUM DECREASED 1 0.0001
841 COLITIS 2 0.0001
842 EYE IRRITATION 3 0.0001
843 DYSTONIA 1 0.0001
844 KIDNEY INFECTION 1 0.0001
845 MENORRHAGIA 1 0.0001
846 DYSPEPSIA 5 0.0001
847 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
848 INJECTION SITE HAEMORRHAGE 4 0.0001
849 CYTOKINE RELEASE SYNDROME 1 0.0000
850 EMOTIONAL DISTRESS 6 0.0000
851 INJURY ASSOCIATED WITH DEVICE 1 0.0000
852 BLINDNESS 2 0.0000
853 BODY TEMPERATURE INCREASED 1 0.0000
854 DEPRESSION 11 0.0000
855 PERITONITIS 1 0.0000
856 HAEMORRHAGE 5 0.0000
857 DERMATITIS 1 0.0000
858 HALLUCINATION, VISUAL 1 0.0000
859 IMPAIRED WORK ABILITY 1 0.0000
860 IRRITABLE BOWEL SYNDROME 1 0.0000
861 LIVER FUNCTION TEST INCREASED 1 0.0000
862 RECTAL HAEMORRHAGE 2 0.0000
863 HYPOACUSIS 2 0.0000
864 RHINORRHOEA 3 0.0000
865 FAECES DISCOLOURED 1 0.0000
866 CONDITION AGGRAVATED 14 0.0000
867 MENTAL DISORDER 2 0.0000
868 BLOOD CREATININE INCREASED 3 0.0000
869 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
870 PRODUCT STORAGE ERROR 4 0.0000
871 GLOSSODYNIA 1 0.0000
872 ORAL PAIN 1 0.0000
873 MEMORY IMPAIRMENT 6 0.0000
874 SKIN IRRITATION 2 0.0000
875 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
876 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
877 INJURY 3 0.0000
878 SLEEP DISORDER 3 0.0000
879 DISEASE RECURRENCE 2 0.0000
880 RASH ERYTHEMATOUS 2 0.0000
881 DIABETIC KETOACIDOSIS 1 0.0000
882 LOCALISED INFECTION 1 0.0000
883 NEURALGIA 1 0.0000
884 CEREBRAL INFARCTION 1 0.0000
885 OSTEONECROSIS OF JAW 1 0.0000
886 AGEUSIA 1 0.0000
887 AGGRESSION 2 0.0000
888 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
889 ABDOMINAL PAIN LOWER 1 0.0000
890 ERECTILE DYSFUNCTION 1 0.0000
891 ILLNESS 4 0.0000
892 HAEMATOMA 1 0.0000
893 EXPOSURE VIA SKIN CONTACT 1 0.0000
894 DEAFNESS 1 0.0000
895 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
896 ANHEDONIA 1 0.0000
897 GASTRITIS 1 0.0000
898 PANCREATITIS 2 0.0000
899 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
900 INJECTION SITE BRUISING 3 0.0000
901 DEHYDRATION 5 0.0000
902 THROMBOSIS 3 0.0000
903 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
904 DISTURBANCE IN ATTENTION 2 0.0000
905 DRY MOUTH 3 0.0000
906 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
907 ABNORMAL DREAMS 1 0.0000
908 DIVERTICULITIS 1 0.0000
909 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
910 SEPSIS 4 0.0000
911 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
913 LIVER FUNCTION TEST ABNORMAL 1 0.0000
914 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
915 NASAL CONGESTION 2 0.0000
916 LABORATORY TEST ABNORMAL 1 0.0000
917 HEPATIC FAILURE 1 0.0000
918 INJECTION SITE RASH 1 0.0000
919 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
920 NASOPHARYNGITIS 6 0.0000
921 OROPHARYNGEAL PAIN 3 0.0000
922 EXPOSURE DURING PREGNANCY 2 0.0000
923 BONE DENSITY DECREASED 1 0.0000
924 ANAEMIA 6 0.0000
925 METABOLIC ACIDOSIS 1 0.0000
926 NIGHT SWEATS 1 0.0000
927 CHOLELITHIASIS 1 0.0000
928 IMPAIRED HEALING 1 0.0000
929 OSTEONECROSIS 1 0.0000
930 INSOMNIA 8 0.0000
931 ANGER 1 0.0000
932 HEPATIC ENZYME INCREASED 2 0.0000
933 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
934 GASTRIC DISORDER 1 0.0000
935 DELIRIUM 1 0.0000
936 NEOPLASM PROGRESSION 1 0.0000
937 HYPERKALAEMIA 1 0.0000
938 DRUG EFFECT INCOMPLETE 1 0.0000
939 ACCIDENTAL OVERDOSE 1 0.0000
940 DRUG INEFFECTIVE 36 0.0000
941 DYSPNOEA EXERTIONAL 1 0.0000
942 HALLUCINATION 2 0.0000
943 HOSPITALISATION 4 0.0000
944 ARTHRITIS 2 0.0000
945 ABNORMAL BEHAVIOUR 1 0.0000
946 PNEUMONIA 8 0.0000
947 EXTRA DOSE ADMINISTERED 1 0.0000
948 RENAL IMPAIRMENT 2 0.0000
949 URINARY TRACT INFECTION 4 0.0000
950 OVERDOSE 5 0.0000
951 BALANCE DISORDER 2 0.0000
952 DEVICE DISLOCATION 1 0.0000
953 LIVER DISORDER 1 0.0000
954 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
955 WEIGHT DECREASED 6 0.0000
956 PRODUCT USE ISSUE 4 0.0000
957 PULMONARY EMBOLISM 2 0.0000
958 NEUROPATHY PERIPHERAL 2 0.0000
959 COLORECTAL CANCER 1 0.0000
960 MULTIPLE SCLEROSIS 1 0.0000
961 DRUG INTOLERANCE 2 0.0000
962 DRY EYE 1 0.0000
963 LEUKOPENIA 1 0.0000
964 FLUID RETENTION 1 0.0000
965 HAEMOGLOBIN DECREASED 2 0.0000
966 INFLAMMATION 1 0.0000
967 DERMATITIS ATOPIC 1 0.0000
968 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
969 OEDEMA 1 0.0000
970 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
971 HAEMATOCHEZIA 1 0.0000
972 FLATULENCE 1 0.0000
973 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
974 IRRITABILITY 1 0.0000
975 JOINT SWELLING 2 0.0000
976 ILL-DEFINED DISORDER 1 0.0000
977 INTENTIONAL OVERDOSE 1 0.0000
978 ALOPECIA 3 0.0000
979 DRY SKIN 2 0.0000
980 PYREXIA 5 0.0000
981 CONSTIPATION 3 0.0000
982 EPISTAXIS 1 0.0000
983 DIABETES MELLITUS 1 0.0000
984 DRUG DOSE OMISSION BY DEVICE 1 0.0000
985 INFLUENZA LIKE ILLNESS 1 0.0000
986 DRUG ABUSE 1 0.0000
987 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
988 COVID-19 2 0.0000
989 INFLUENZA 1 0.0000
990 WEIGHT INCREASED 2 0.0000
991 NEUTROPENIA 1 0.0000
992 DRUG DEPENDENCE 1 0.0000
993 DECREASED APPETITE 1 0.0000